Testosterone patients urged to get new scripts as sachets go out of stock

Patients being treated with Testogel (1% transdermal testosterone gel) will have to switch to an alternative product because the sachet formulation is now out of stock for months, the manufacturer says. Besins Healthcare is advising patients using Testogel to visit their treating clinician as soon as possible to get a new prescription for its metered ...

Already a member?

Login to keep reading.

© 2021 the limbic